149 related articles for article (PubMed ID: 25971726)
1. Protein MRI contrast agent with unprecedented metal selectivity and sensitivity for liver cancer imaging.
Xue S; Yang H; Qiao J; Pu F; Jiang J; Hubbard K; Hekmatyar K; Langley J; Salarian M; Long RC; Bryant RG; Hu XP; Grossniklaus HE; Liu ZR; Yang JJ
Proc Natl Acad Sci U S A; 2015 May; 112(21):6607-12. PubMed ID: 25971726
[TBL] [Abstract][Full Text] [Related]
2. Precision detection of liver metastasis by collagen-targeted protein MRI contrast agent.
Salarian M; Yang H; Turaga RC; Tan S; Qiao J; Xue S; Gui Z; Peng G; Han H; Mittal P; Grossniklaus HE; Yang JJ
Biomaterials; 2019 Dec; 224():119478. PubMed ID: 31542517
[TBL] [Abstract][Full Text] [Related]
3. Early detection and staging of chronic liver diseases with a protein MRI contrast agent.
Salarian M; Turaga RC; Xue S; Nezafati M; Hekmatyar K; Qiao J; Zhang Y; Tan S; Ibhagui OY; Hai Y; Li J; Mukkavilli R; Sharma M; Mittal P; Min X; Keilholz S; Yu L; Qin G; Farris AB; Liu ZR; Yang JJ
Nat Commun; 2019 Oct; 10(1):4777. PubMed ID: 31664017
[TBL] [Abstract][Full Text] [Related]
4. In vivo labeling of B16 melanoma tumor xenograft with a thiol-reactive gadolinium based MRI contrast agent.
Menchise V; Digilio G; Gianolio E; Cittadino E; Catanzaro V; Carrera C; Aime S
Mol Pharm; 2011 Oct; 8(5):1750-6. PubMed ID: 21780833
[TBL] [Abstract][Full Text] [Related]
5. Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRI.
Pu F; Salarian M; Xue S; Qiao J; Feng J; Tan S; Patel A; Li X; Mamouni K; Hekmatyar K; Zou J; Wu D; Yang JJ
Nanoscale; 2016 Jul; 8(25):12668-82. PubMed ID: 26961235
[TBL] [Abstract][Full Text] [Related]
6. MR imaging of blood-borne liver metastases in mice: contrast enhancement with Fe-EHPG.
Shtern F; Garrido L; Compton C; Swiniarski JK; Lauffer RB; Brady TJ
Radiology; 1991 Jan; 178(1):83-9. PubMed ID: 1984329
[TBL] [Abstract][Full Text] [Related]
7. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
[TBL] [Abstract][Full Text] [Related]
8. Chemokine receptor 4 targeted protein MRI contrast agent for early detection of liver metastases.
Tan S; Yang H; Xue S; Qiao J; Salarian M; Hekmatyar K; Meng Y; Mukkavilli R; Pu F; Odubade OY; Harris W; Hai Y; Yushak ML; Morales-Tirado VM; Mittal P; Sun PZ; Lawson D; Grossniklaus HE; Yang JJ
Sci Adv; 2020 Feb; 6(6):eaav7504. PubMed ID: 32083172
[TBL] [Abstract][Full Text] [Related]
9. Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.
Schnorr J; Wagner S; Abramjuk C; Drees R; Schink T; Schellenberger EA; Pilgrimm H; Hamm B; Taupitz M
Radiology; 2006 Jul; 240(1):90-100. PubMed ID: 16684917
[TBL] [Abstract][Full Text] [Related]
10. Designing Calcium-Binding Proteins for Molecular MR Imaging.
Salarian M; Xue S; Ibhagui OY; Yang JJ
Methods Mol Biol; 2019; 1929():111-125. PubMed ID: 30710270
[TBL] [Abstract][Full Text] [Related]
11. Protein MRI Contrast Agents as an Effective Approach for Precision Molecular Imaging.
Li D; Kirberger M; Qiao J; Gui Z; Xue S; Pu F; Jiang J; Xu Y; Tan S; Salarian M; Ibhagui O; Hekmatyar K; Yang JJ
Invest Radiol; 2024 Feb; 59(2):170-186. PubMed ID: 38180819
[TBL] [Abstract][Full Text] [Related]
12. Free-breathing quantitative dynamic contrast-enhanced magnetic resonance imaging in a rat liver tumor model using dynamic radial T(1) mapping.
Braren R; Curcic J; Remmele S; Altomonte J; Ebert O; Rummeny EJ; Steingoetter A
Invest Radiol; 2011 Oct; 46(10):624-31. PubMed ID: 21577121
[TBL] [Abstract][Full Text] [Related]
13. Assessment of tumor radioresponsiveness and metastatic potential by dynamic contrast-enhanced magnetic resonance imaging.
Øvrebø KM; Gulliksrud K; Mathiesen B; Rofstad EK
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):255-61. PubMed ID: 21816291
[TBL] [Abstract][Full Text] [Related]
14. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive detection and complementary diagnosis of liver metastases via chemokine receptor 4 imaging.
Yang H; Tan S; Qiao J; Xu Y; Gui Z; Meng Y; Dong B; Peng G; Ibhagui OY; Qian W; Lu J; Li Z; Wang G; Lai J; Yang L; Grossniklaus HE; Yang JJ
Cancer Gene Ther; 2022 Dec; 29(12):1827-1839. PubMed ID: 35145271
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging.
Langereis S; de Lussanet QG; van Genderen MH; Meijer EW; Beets-Tan RG; Griffioen AW; van Engelshoven JM; Backes WH
NMR Biomed; 2006 Feb; 19(1):133-41. PubMed ID: 16450331
[TBL] [Abstract][Full Text] [Related]
17. Dynamic micro-magnetic resonance imaging of liver micrometastasis in mice with a novel liver macromolecular magnetic resonance contrast agent DAB-Am64-(1B4M-Gd)(64).
Kobayashi H; Saga T; Kawamoto S; Sato N; Hiraga A; Ishimori T; Konishi J; Togashi K; Brechbiel MW
Cancer Res; 2001 Jul; 61(13):4966-70. PubMed ID: 11431325
[TBL] [Abstract][Full Text] [Related]
18. Polyamine-substituted gadolinium chelates: a new class of intracellular contrast agents for magnetic resonance imaging of tumors.
Wolf M; Hull WE; Mier W; Heiland S; Bauder-Wüst U; Kinscherf R; Haberkorn U; Eisenhut M
J Med Chem; 2007 Jan; 50(1):139-48. PubMed ID: 17201417
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced magnetic resonance imaging of the metastatic potential of melanoma xenografts.
Ovrebø KM; Ellingsen C; Galappathi K; Rofstad EK
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e121-7. PubMed ID: 22381901
[TBL] [Abstract][Full Text] [Related]
20. Design of ProCAs (protein-based Gd(3+) MRI contrast agents) with high dose efficiency and capability for molecular imaging of cancer biomarkers.
Xue S; Qiao J; Jiang J; Hubbard K; White N; Wei L; Li S; Liu ZR; Yang JJ
Med Res Rev; 2014 Sep; 34(5):1070-99. PubMed ID: 24615853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
